Wells Fargo Maintains Overweight on GE HealthCare Techs, Raises Price Target to $96
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Larry Biegelsen maintains an Overweight rating on GE HealthCare Techs and raises the price target from $95 to $96.
October 31, 2024 | 8:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo analyst Larry Biegelsen has maintained an Overweight rating on GE HealthCare Techs and increased the price target from $95 to $96.
The increase in price target and maintained Overweight rating by a reputable analyst from Wells Fargo is likely to positively influence investor sentiment and could lead to a short-term increase in GE HealthCare Techs' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100